Abcellera Biologics Inc
NASDAQ:ABCL
Abcellera Biologics Inc
NASDAQ:ABCL
Price:
6.17
USD
7.68%
Market Closed
Market Cap:
$1.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Abcellera Biologics Inc
NASDAQ:ABCL
|
CA |
|
Ence Energia y Celulosa SA
MAD:ENC
|
ES |
|
Nine Dragons Paper (Holdings) Ltd
F:N3Y
|
HK |
|
Pharming Group NV
AEX:PHARM
|
NL |
|
EROAD Ltd
NZX:ERD
|
NZ |
|
Accolade Inc
NASDAQ:ACCD
|
US |
Wall St Price Targets
ABCL Price Targets Summary
Abcellera Biologics Inc
Abcellera Biologics Inc
Wall Street analysts forecast ABCL stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for ABCL is 10.35 USD with a low forecast of 7.07 USD and a high forecast of 13.65 USD.
Lowest Forecast
Price Target
7.07
USD
15% Upside
Average Forecast
Price Target
10.35
USD
68% Upside
Highest Forecast
Price Target
13.65
USD
121% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABCL's stock price target?
Price Target
10.35
USD
10.35
USD
According to Wall Street analysts, the average 1-year price target for ABCL is 10.35 USD with a low forecast of 7.07 USD and a high forecast of 13.65 USD.
What is the Revenue forecast for Abcellera Biologics Inc?
Projected CAGR
30%
30%
Over the last 6 years, the compound annual growth rate for Revenue has been 37%. The projected CAGR for the next 8 years is 30%.
